ABSTRACT -In order to investigate the effect of sunlight on the persistence and ecotoxicity of pharmaceuticals contaminating the aquatic environment, we exposed nine pharmaceuticals (acetaminophen (AA), amiodarone (AM), dapsone (DP), dexamethasone (DX), indomethacin (IM), naproxen (NP), phenytoin (PH), raloxifene (RL), and sulindac (SL)) in aqueous media to sunlight and to ultraviolet (UV) irradiation at 254, 302 or 365 nm (UV-C, UV-B or UV-A, respectively). Degradation of the pharmaceuticals was monitored by means of high-performance liquid chromatography (HPLC). Sunlight completely degraded AM, DP and DX within 6 hr, and partly degraded the other pharmaceuticals, except AA and PH, which were not degraded. Similar results were obtained with UV-B, while UV-A was less effective (both UV-A and -B are components of sunlight). All the pharmaceuticals were photodegraded by UV-C, which is used for sterilization in sewage treatment plants. Thus, the photodegradation rates of pharmaceuticals are dependent on both chemical structure and the wavelength of UV exposure. Toxicity assay using the luminescent bacteria test (ISO11348) indicated that UV irradiation reduced the toxicity of some pharmaceuticals to aquatic organisms by decreasing their amount (photodegradation) and increased the toxicity of others by generating toxic photoproduct(s). These results indicate the importance of investigating not only parent compounds, but also photoproducts in the risk assessment of pharmaceuticals in aquatic environments.
INTRODUCTION
Many pharmaceuticals are discharged into the aquatic environment in either intact or modified form after having been administered to humans and livestock and subsequently excreted via urine, and pharmaceutical residues have been detected at levels in the range of ng/l to μg/l (Kuster et al., 2008; Ginebreda et al., 2010; Rosal et al., 2010) . Processing at sewage treatment plants (STPs) is able to remove various pharmaceuticals. For example, pharmaceuticals in STP influent can be removed by membrane bioreactor and activated sludge processes (Jones et al., 2007; De Gusseme et al., 2011) , while ultraviolet (UV) treatment, used for disinfecting polluted water, has also been reported to remove pharmaceuticals as a result of UV-induced photodegradation and transformation into other compounds (Maquille et al., 2010; Tong et al., 2011) . Other reports indicate that pharmaceuticals can be removed from the aquatic environment in various ways, including sorption, biodegradation and photodegradation in sunlight (Teeter and Meyerhoff, 2002; Yamamoto et al., 2009; Ioele et al., 2010; Lin et al., 2010) . However, they are not necessarily inactivated or removed completely, and some persist in the aquatic environment.
Due to the growing number of reports on the persistence of pharmaceuticals in aquatic environments and possible ecotoxicological effects on aquatic organisms, pharmaceuticals are now considered as important envi-ronmental contaminants. For risk assessment, many ecotoxicological tests are available, using aquatic organisms such as Daphnia magna, Oryzias latipes and Brachinous calyciflorus Isidori et al., 2005; Crane et al., 2006) . Moreover, the SOS chromotest and Ames test have been utilized to detect the genotoxic potential of pharmaceuticals for aquatic organisms (Isidori et al., 2009; Liu et al., 2012) . Examination of the influence of pharmaceuticals on aquatic organisms has become an important issue.
The toxicity of pharmaceuticals to aquatic organisms may be affected by various factors, especially UV irradiation. For example, it was reported that the ecotoxicological effects of pharmaceuticals may be increased or decreased by UV irradiation (Liu et al., 2009; Trovo et al., 2009) . Photodegradation is one of the main determinants of the environmental persistence and ecotoxicological activity of pharmaceuticals in the aquatic environment.
The aim of the present study is to examine the photodegradation of various pharmaceuticals by sunlight and UV irradiation at various wavelengths, and to evaluate the consequent changes of toxicity to aquatic organisms.
MATERIALS AND METHODS

Materials
Acetaminophen, dexamethasone, dimethyl sulfoxide and sodium chloride were purchased from Wako Pure Chemicals (Osaka, Japan), amiodarone was purchased from LKT Laboratories (St. Paul, MN, USA), phenytoin was purchased from Tokyo Chemical Industry (Tokyo, Japan), indomethacin was purchased from Nacalai Tesque (Kyoto, Japan), (S)-naproxen was purchased from Cayman Chemical (Ann Arbor, MI, USA), methanol was purchased from Kanto Chemical (Tokyo, Japan), sulindac, dapsone, raloxifene chloride, ethanol and acetic acid were purchased from Sigma-Aldrich (Poole, UK). Milli-Q (18.2 Ω/cm) water was prepared by using a Milli-Q water purification system (Millipore, Billerica, MA, USA).
UV spectral analysis
All test compounds were dissolved in ethanol at the final concentration of 10-100 μM. UV absorption spectra were recorded with a Beckman DU-640 spectrophotometer (Beckman Coulter Instruments, Brea, CA, USA) interfaced to a PC for data processing. The absorptionmaximum wavelength (λ max , nm) was obtained from these results. The molar absorbance coefficient (ε) of each pharmaceutical was calculated from the absorbance at λ max .
Irradiation experiments
Sunlight irradiation experiments were performed during summer in Hiroshima, Japan. A solution of each pharmaceutical in Milli-Q water (50 μg/50 ml) was exposed to sunlight in a quartz test tube. Exposure details are given in Table 1 . UV irradiation was carried out in light cabinets equipped with electrical discharge tubes (15W FL15BLB-A black light lamp (Toshiba, Tokyo, Japan), 6W UVM-57 Handheld UV lamp and 6W UVGL-58 Handheld UV lamp (UVP, Upland, CA, USA)) and filters to provide exposure at 365 nm (UV-A), 302 nm (UV-B) and 254 nm (UV-C) (irradiation intensity values: UV-A 1800 μW/cm 2 /sec, UV-B 1250 μW/cm 2 /sec, UV-C 170 μW/cm 2 /sec at 15 cm from the source). Irradiation intensity was measured using a digital radiometer equipped with 365 and 302 nm sensors (UVX-36 and UVX-31, UVP) and a 254 nm sensor (UV-37SD, CUSTOM, Tokyo, Japan). A solution of each pharmaceutical in Milli-Q water (50 μg/50 ml) was irradiated in a glass vessel (water depth 3 cm, distance from lamp source about 15 cm) for 0, 6, 12 and 24 hr at 20°C. In the case of UV-C irradiation, the irradiation time was extended to 96 hr. Control samples were covered with aluminum foil to exclude light. Samples exposed to sunlight or UV were concentrated by solid-phase extraction using Oasis HLB 3cc cartridges (Waters Corp., Milford, USA) in a multi-sample concentration system (Varian Sample Preparation Vac Elute SPS 24, Lab Extreme, Kent City, MI, USA). Samples were eluted using methanol (2 ml), and concentrated under reduced pressure. The residues were dissolved in methanol (500 μl). The decrease of pharmaceuticals was monitored with a high-performance liquid chromatography (HPLC) (L-7110, Hitachi, Tokyo, Japan) system equipped with an Inertsil ODS-3 column (5 μm, 4.6 × 150 mm, GL Sciences Inc., Tokyo, Japan), a UV detector (L-7440, Hitachi) and a Chromato-Integrator (D-2500, Hitachi). The UV detector was set at the wavelength of 254 nm. The isocratic mobile phase consisted of 0.1% acetic acid and methanol, flowing at 0.5 ml/min. HPLC conditions are summarized in Table 2 .
Luminescent bacteria test
The luminescent bacteria test was carried out according to ISO11348. This method is based on measuring the decrease of light emission of luminescent bacteria (Photobacterium phosphoreum), which is related to the level of toxic stress. Luminescence was measured with a multilabel counter (ARVO TM MX, Perkin Elmer, Waltham, MA, USA). Toxic effects were expressed as median effective concentration (EC 50 , mg/l). Sample preparation was conducted as follows; a pharmaceutical (1 mg) was initially dissolved in dimethyl sulfoxide (DMSO, 50 μl) and the solution was diluted further with Milli-Q water (950 μl). Then 22% sodium chloride solution (NaCl aq, 100 μl) was added in order to make the NaCl concentration of the sample equal to 2%. This sample was diluted 2, 4, 8, 16, 32, 64 and 128 times using 2% NaCl aq. A control sample without the pharmaceutical was also prepared. A photo-exposed sample was prepared as follows; a solution of a pharmaceutical in methanol (1 mg/ml, 1 ml) was added to Milli-Q water and exposed to UV irradiation (AA and PH were irradiated with UV-C for 24 hr, and other pharmaceuticals were irradiated with UV-B for 6 hr). Then the irradiated sample was concentrated 100-fold by solid-phase extraction. The residue was used as a sample for the luminescent bacteria test as before. Measurements of light emission were made with a multilabel counter after an exposure time of 15 min and compared to the control value. Toxicity was evaluated by calculating the decrease of light emission compared to the control sample.
Statistical analysis
Results of the luminescent bacteria test, which indicated the half maximal effective concentration (EC 50 ), were expressed as the mean ± standard deviation (S.D.). EC 50 was calculated using Probit analysis (Ecotox Statics ver. 2.3; The Japanese Society of Environmental Toxicology).
RESULTS AND DISCUSSION
Photodegradation of pharmaceuticals by sunlight
In this study, we investigated the effects of sunlight and UV irradiation on nine pharmaceuticals: the analgetic drug acetaminophen (AA), antimicrobial drug dapsone (DP), bone-building drug raloxifene (RL), antiepilepsy drug phenytoin (PH), steroidal anti-inflammatory drug dexamethasone (DX), antiarrhythmic drug amiodarone (AM), and NSAIDs indomethacin (IM), naproxen (NP) and sulindac (SL). The structures of these pharma- ceuticals are shown in Fig. 1 . These pharmaceuticals are all used in Japan, and might be discharged into the aquatic environment. The persistence of most of these pharmaceuticals in the aquatic environment has previously been examined (Table 3 ), but this is the first report dealing with AM and RL, although it was suggested that AM and RL might persist in the aquatic environment and should be further investigated (Howard and Muir, 2011) . UV irradiation wavelengths of 365, 302 and 254 nm were chosen, because UV at 302 nm and 365 nm is present in sunlight, and UV at 254 nm is utilized for sterilization in STPs. First, the UV absorption spectra of the nine pharmaceuticals in ethanol were measured with a spectrophotometer, and the absorption-maximum wavelength (λ max , nm) and molar absorbance coefficient (ε) were determined (Table 4 ). All pharmaceuticals showed significant absorption in the UV-C region.
Next, the photodegradation of pharmaceuticals by sunlight was monitored by means of HPLC. All the pharmaceuticals except for AA and PH showed decreases of peak area in HPLC analysis after exposure to sunlight for 6 hr (Fig. 2) . This is consistent with the results of UV spectral analysis (Table 4) . AM, DP and DX were photodegraded completely within 6 hr, while degradation of the other pharmaceuticals amounted to about 50%. Moreover, the appearance of new peaks indicated the generation of photoproducts in sunlight (data not shown). Photodegradation of pharmaceuticals in sunlight has been reported by other groups (Yamamoto et al., 2009; Ioele et al., 2010) . In our experiment, the control was unchanged, confirming that degradation of the test pharmaceuticals was not due to other factors, such as hydrolysis (data not shown).
Photodegradation of pharmaceuticals by UV irradiation
All the pharmaceuticals except for AA, IM and PH were photodegraded after UV-A irradiation (Fig. 3) . AM and DX were photodegraded completely, as was the case in sunlight. Under UV-B irradiation, all the pharmaceuticals except for AA and PH were degraded (Fig. 4) . AM, DP and DX were photodegraded completely, while the other five pharmaceuticals were degraded to the extent of less than 50%. Sunlight reaches the surface of the earth after passage through the atmosphere, resulting a wave-
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Dapsone ( length cut-off just below 300 nm, so that the spectrum of sunlight is composed of UV-A, UV-B and visible light. Therefore, the results with UV-A and UV-B were consistent with those in sunlight, as expected. These pharmaceuticals, including AA and PH, were completely photodegraded after UV-C irradiation (Fig. 5) , except for NP and RL, which were degraded to a level of less than 50%. UV-C is used for sterilization in STPs, so our results indicate that UV-C irradiation would photodegrade pharmaceuticals present in STP influents. It appears that pharmaceuticals are photodegraded faster at shorter UV wavelength. This is as expected, since the energy of the radiation is higher at shorter wavelength, and is also in agreement with reported findings (Kim and Tanaka, 2009) .
Photodegradation occurs when compounds in the ground state absorb light energy, forming an excited state that triggers a photochemical reaction such as bond cleavage. AM, DP and DX were photodegraded rapidly, as expected from their chemical structures or functional groups. Rapid photodegradation of DX by UV irradiation (340-400 nm) in the presence of TiO 2 as a photocatalyst has been reported, and the structures of various photoproducts were determined (Calza et al., 2001) . It has also been reported that fluoroquinolones are photodegraded rapidly in sunlight in the presence or absence of photocatalysts, and the main photodegradation pathways are defluorination and amine side-chain oxidation (Sturini et al., 2012) . Various photodegradation reactions may be induced by UV irradiation, including photo-adduct formation, photo-oxidation, photo-rearrangement, photo-cyclization, decarboxylation, and dehalogenation (Konstantinou et al., 2002; Petrovic and Barcelo, 2007; Miolo et al., 2011) . Generally, photodegradation in the presence of photocatalysts is mechanistically more complex because of the generation of many photoproducts via photo-generated hydroxyl and other radicals (Radjenovic et al., 2010) .
In future work, it will be important to identify the photoproducts generated after UV irradiation, and to establish their aquatic environmental fate and ecotoxicological significance. For example, the diuretic drug furosemide is photo-transformed into the dimer , which has mutagenic potential (Isidori et al., 2006) . Photodegradation of various other pharmaceuticals has also been reported (Breier et al., 2008; Calisto et al., 2011; Skibinski, 2011) , but the influence of these reactions on ecotoxicity has generally not been examined.
Luminescent bacterium test
The effects of solutions of the test pharmaceuticals and photo-exposed pharmaceuticals on aquatic organisms were investigated by means of the luminescent bacteria test. Before UV irradiation, AA, DX and PH had no effect, and so EC 50 values could not be calculated (Table 5) . Other pharmaceuticals showed toxicity, and NSAIDs, including IM, NP and SL, were especially toxic. UV-Birradiated DP, DX and SL showed marked toxicity, and the EC 50 values were lower than the values before UV-B irradiation, i.e, toxicity was increased. On the other hand, the effects of other pharmaceuticals on aquatic organisms were weakened after UV-B irradiation. Thus, the toxicity of the generated photoproducts appears to be a key issue. UV-C irradiated AA and PH showed toxicity to aquatic organisms (EC 50 : 29.5 mg/l for AA and 19.5 mg/l for PH, Table 6 ), indicating that their photoproducts contribute to the increase of toxicity. Photodegradation of AA and PH in the presence of photocatalysts has been reported (Parman et al., 1998; Zhang et al., 2007) , but this is the first report to show that they are also photodegraded in the absence of photocatalysts.
In this research, the toxic concentration range of the pharmaceuticals and photo-exposed pharmaceuticals solution was of mg/l order, being considerably higher than the concentrations at which pharmaceuticals have generally been detected in aquatic environments (μg/l-ng/l). Nevertheless, our results illustrate the potential importance of investigating the toxicity of not only parent compounds, but also potential photoproducts as a part of the environmental risk assessment of pharmaceuticals. There are several reports indicating that the toxicity of pharmaceuticals to aquatic organisms can be altered by UV irradiation. For example, the beta-adrenergic antagonist propranolol was reported to be transformed into less toxic compounds by UV irradiation (Liu et al., 2009) , while the antibiotic sulfamethoxazole was transformed into more toxic compounds (Trovo et al., 2009) . Our results re-emphasize the importance of considering the effects of UV irradiation on the ecotoxicity of pharmaceuticals in aquatic environments.
In conclusion, we have shown that pharmaceuticals are photodegraded by sunlight and UV irradiation, resulting in changes of ecotoxicity. The outcome of photodegradation is dependent on many factors, including chemical structure, the kinds of functional groups and the wavelength of UV exposure. Our results emphasize the need for further investigation, because the photochemical behavior of many pharmaceuticals and the potential ecotoxicity of their photoproducts are largely unknown.
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